QV Bioelectronics careers

Time is precious

For Patients with the most common brain tumour, glioblastoma, the value of that time really comes into focus when they are suddenly hit with the news there is no cure and that they have just one year to live.

Current treatment options are not good enough and come at a huge cost to the quality of that remaining time.

QV Bioelectronics is raising 700 thousands dollars to develop a novel implanted electrotherapy device which will deliver continuous, pain and side effect free treatment right at the site of the cancer.

Doubling patient life expectancy compared to standard treatment without impacting quality of life, so they can focus on what matters. The market for this proprietary technology is worth $4.7Bn a year.

Our team has the expertise to make this happen, leveraging twice as much non-dilutive funding, for every dollar of investment to date.

Join us at QV Bioelectronics, in pioneering a better option for terminal cancer patients.